Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.

Farace, F; Gross-Goupil, M; Tournay, E; Taylor, M; Vimond, N; Jacques, N; Billiot, F; Mauguen, A; Hill, C; Escudier, B

Farace, F; Gross-Goupil, M; Tournay, E; Taylor, M; Vimond, N; Jacques, N; Billiot, F; Mauguen, A; Hill, C; Escudier, B.

Affiliation

Farace F; Translational Research Laboratory, Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France. farace@igr.fr

Br J Cancer ; 104(7): 1144-50, 2011 Mar 29.

Article in En | MEDLINE | ID: mdl-21386843

Subject(s)

Antigens, CD34/blood; Carcinoma, Renal Cell/drug therapy; Hematopoietic Stem Cells/physiology; Kidney Neoplasms/drug therapy; Leukocyte Common Antigens/blood; Protein Kinase Inhibitors/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Vascular Endothelial Growth Factor Receptor-2/blood; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell/blood; Carcinoma, Renal Cell/mortality; Carcinoma, Renal Cell/secondary; Female; Humans; Kidney Neoplasms/blood; Kidney Neoplasms/mortality; Kidney Neoplasms/pathology; Male; Middle Aged; Treatment Outcome; Vascular Endothelial Growth Factor A/blood

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Hematopoietic Stem Cells / Carcinoma, Renal Cell / Leukocyte Common Antigens / Antigens, CD34 / Vascular Endothelial Growth Factor Receptor-2 / Protein Kinase Inhibitors / Kidney Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2011 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google